{"symbol":"AMGN","provider":"yahoo-finance","fetchedAt":"2025-12-24T18:21:28.503Z","asOfDate":"2025-12-24","articles":[{"id":"b24a246a-6397-39aa-9b8e-de96f1593f9d","title":"Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know","url":"https://finance.yahoo.com/news/amgen-strikes-drug-pricing-deal-153300363.html","publisher":"Zacks","publishedAt":"2025-12-24T15:33:00.000Z","relatedTickers":["BMY","GLAXF","GSK","MRK"],"mainIdea":"Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know","summary":"Zacks: Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know. AMGN signs a pricing deal with the Trump administration, cutting U.S. drug costs, expanding DTC access and securing tariff relief tied to domestic investment. Related tickers mentioned: BMY, GLAXF, GSK, MRK."},{"id":"4c3b6c72-7150-31dc-9ab3-543dbf8aeb04","title":"Should You Be Excited About Amgen Inc.'s (NASDAQ:AMGN) 73% Return On Equity?","url":"https://finance.yahoo.com/news/excited-amgen-inc-nasdaq-amgn-110023824.html","publisher":"Simply Wall St.","publishedAt":"2025-12-24T11:00:23.000Z","relatedTickers":[],"mainIdea":"Should You Be Excited About Amgen Inc.'s (NASDAQ:AMGN) 73% Return On Equity?","summary":"Simply Wall St.: Should You Be Excited About Amgen Inc.'s (NASDAQ:AMGN) 73% Return On Equity?. One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will..."},{"id":"db37c64f-c540-3db5-ad9c-e926111259bd","title":"Halozyme Therapeutics Stock Sees Relative Strength Rating","url":"https://finance.yahoo.com/m/db37c64f-c540-3db5-ad9c-e926111259bd/halozyme-therapeutics-stock.html","publisher":"Investor's Business Daily","publishedAt":"2025-12-23T17:42:32.000Z","relatedTickers":["HALO"],"mainIdea":"Halozyme Therapeutics Stock Sees Relative Strength Rating","summary":"Investor's Business Daily: Halozyme Therapeutics Stock Sees Relative Strength Rating. Halozyme Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating Related tickers mentioned: HALO."},{"id":"835f1203-774b-3bde-9adb-960484c0e4bf","title":"Novo Nordisk vs. Amgen: Which Healthcare Stock Is the Smarter Choice?","url":"https://finance.yahoo.com/news/novo-nordisk-vs-amgen-healthcare-151400304.html","publisher":"Zacks","publishedAt":"2025-12-23T15:14:00.000Z","relatedTickers":["LLY","NONOF","NVO"],"mainIdea":"Novo Nordisk vs. Amgen: Which Healthcare Stock Is the Smarter Choice?","summary":"Zacks: Novo Nordisk vs. Amgen: Which Healthcare Stock Is the Smarter Choice?. NVO and AMGN square off as GLP-1 leadership, pipeline depth, and diversification set up a compelling healthcare stock comparison. Related tickers mentioned: LLY, NONOF, NVO."},{"id":"365f8e8a-12dd-3afc-b85f-9a89dded47c3","title":"5 Big Drug Stocks That May Continue to Outperform in 2026","url":"https://finance.yahoo.com/news/5-big-drug-stocks-may-134800671.html","publisher":"Zacks","publishedAt":"2025-12-23T13:48:00.000Z","relatedTickers":["ABBV","JNJ","LLY","^GSPC"],"mainIdea":"5 Big Drug Stocks That May Continue to Outperform in 2026","summary":"Zacks: 5 Big Drug Stocks That May Continue to Outperform in 2026. Five big drugmakers, including LLY and JNJ, are riding innovation, dealmaking and pipeline momentum that could help them keep outperforming in 2026. Related tickers mentioned: ABBV, JNJ, LLY, ^GSPC."}]}
